HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Treatment with topical corticosteroids in severe or resistant dermatoses].

Abstract
The efficacy and safety of betamethasone dipropionate glycol cream 0.05% and desoximetasone ointment 0.25% were compared in a randomized, double-blind study of 80 patients with resistant or severe corticosteroid-responsive dermatoses. Medication was applied to affected areas at a dosage of 3.5 grams twice daily for 14 days. In each treatment group, evaluation of efficacy was based on results in 35 patients and that of safety in 40 patients. Among betamethasone dipropionate glycol cream 0.05%-treated patients, signs and symptoms of dermatologic disease either cleared completely or markedly improved in 34/35 (97%). Comparable responses were observed in 31/35 (89%) patients treated with desoximetasone ointment 0.25%. Local tolerance to both study medications was excellent; no adverse reactions occurred. Plasma cortisol reduction occurred in few patients (4 resp. 3 patients each group), however this effect was only transient and reversible.
AuthorsS Nolting
JournalDermatosen in Beruf und Umwelt. Occupation and environment (Derm Beruf Umwelt) Vol. 33 Issue 4 Pg. 140-4 ( 1985) ISSN: 0343-2432 [Print] Germany
Vernacular TitleBehandlung mit Kortikosteroid-Externa bei schweren oder resistenten Dermatosen.
PMID2931266 (Publication Type: Clinical Trial, Comparative Study, English Abstract, Journal Article, Randomized Controlled Trial)
Chemical References
  • Ointments
  • Desoximetasone
  • Dexamethasone
  • betamethasone-17,21-dipropionate
  • Betamethasone
  • Hydrocortisone
Topics
  • Adolescent
  • Adult
  • Aged
  • Betamethasone (analogs & derivatives, therapeutic use)
  • Clinical Trials as Topic
  • Dermatitis, Atopic (drug therapy)
  • Dermatitis, Seborrheic (drug therapy)
  • Desoximetasone (therapeutic use)
  • Dexamethasone (analogs & derivatives)
  • Double-Blind Method
  • Drug Tolerance
  • Female
  • Humans
  • Hydrocortisone (blood)
  • Male
  • Middle Aged
  • Ointments
  • Psoriasis (drug therapy)
  • Safety
  • Skin Diseases (drug therapy)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: